Resumo: A COVID-19 tem representado um desafio global aos sistemas de saúde, expandindo em velocidade crescente de óbitos, de pacientes críticos com pneumonia e necessidade de suporte respiratório. Métodos alternativos para controlar a propagação da doença, como o isolamento social, medidas extremas de quarentena e o rastreio dos contactantes dos casos têm sido utilizados no mundo. Contudo, essas medidas podem não ser totalmente eficazes para combater a escalada da COVID-19 em compasso às preparações nacionais necessárias às novas demandas de cuidado. Ampla gama de tecnologias digitais pode ser usada para aprimorar essas estratégias de saúde pública, e a pandemia gerou um frenesi relacionado à telessaúde. No Brasil, esse campo tem crescido acentuadamente nos últimos anos. Todavia, a despeito da intensa proliferação de normativas, ainda inexistia, até a epidemia, um marco regulatório plenamente consolidado no país. O surgimento da COVID-19 marca um momento profícuo de expansão das aplicações e usos da telessaúde, como forma de melhorar a resposta do sistema de saúde à crise em curso. O artigo discute a contribuição da telessaúde para o enfrentamento da COVID-19 e as iniciativas recentes desencadeadas no país, como oportunidades para a consolidação da telemedicina e de aperfeiçoamento do Sistema Único de Saúde. Concluiu-se que a telessaúde oferece capacidades para triagem, cuidado e tratamento remotos, auxilia o monitoramento, vigilância, detecção e prevenção, e para a mitigação dos impactos aos cuidados de saúde indiretamente relacionados a COVID-19. As iniciativas desencadeadas nesse processo podem reconfigurar o espaço futuro da telemedicina na prática dos serviços no território.

This article examines pharmaceutical services and access to essential medicines in Brazil during the 30 years since the advent of Brazil's Unified Health System from a comprehensiveness perspective. The following topics are addressed: the "realignment" of pharmaceutical services; human resources in pharmaceutical services; the essential medicines concept; the rational use of medicines; technological advances and drug manufacturing; and ethical regulation. With a strong regulatory focus and a structural framework centered on the National Medicines Policy, the past three decades represent a mixture of progress and setbacks, considering the national complexities of the healthcare system and the political, economic and social changes that have influenced policy and access to medicines, which is a key concern even in the world's richest countries, as the forums of discussion on global health have demonstrated. We show that major steps forward have been taken, highlighting that the recent fiscal austerity measures imposed by the government threaten to seriously undermine social progress.

The National Commission for incorporation of Health Technologies (CONITEC),

(18) Fluorodeoxyglucose (FDG)-PET and PET-CT are highly accurate diagnostics tools for DTC recurrence in patients who present a negative whole-body scintigraphy and could impact the clinical and therapeutic management of DTC.

The "Farmácia Popular do Brasil" Program (PFPB)

No abstract

This study characterized the evolution of Brazilian public telemedicine policy in the Brazilian Unified Health System for 30 years from 1988 to 2019 by analyzing its legal framework. We identified 79 telemedicine-related legislations from the federal government (laws, decrees, and ordinances) and 31 regulations of federal councils of health professionals. Three historical phases were established according to the public policy cycle, and material was classified according to the purpose of the normative documents. The content analysis was based on the advocacy coalition framework model. Of the federal legislations, 8.9% were for the Formulation/Decision-Making phase, 43% for the Organization/Implementation phase, and 48.1% for the Expansion/Maturation phase of telemedicine policy in Brazil. The Federal Council of Medicine was the most active in standardizing telemedicine and was responsible for 21 (67.7%) regulations. The first legislations were passed in 2000; however, the coalitions discussed topics related to telemedicine and created their belief systems from the 1990’s. The time cycle which included formulation and decision making for Brazilian telemedicine policy, extended until 2007 with the creation of several technical working groups. The expansion and maturation of telemedicine services began in 2011 with the decentralization of telemedicine policy actions across the country. Telemedicine centers which performed telediagnosis influenced the computerization of primary health care units. We conclude that Brazilian telemedicine field has greatly grown and changed in recent years. However, despite the proliferation of legislations and regulations in the period studied, there is still no fully consolidated process for setting up a wholly defined regulatory framework for telemedicine in Brazil.

Pharmaceutical services in rio de